[1] 沈卫峰, 张奇, 张瑞岩. 2015年急性ST段抬高型心肌梗死诊断和治疗指南解析[J].国际心血管病杂志, 2015, 42(4):217-219.
[2] 沈杨, 裴丽丽, 王业勤,等. 急性ST段抬高型心肌梗死冠状动脉介入溶栓治疗术后心电图变化和心功能的关系[J].中国老年学杂志, 2017, 37(2):352-353.
[3] 魏鹏, 杨向军, 付强,等. 替格瑞洛对急性ST段抬高型心肌梗死患者血清hs-CRP和ESM-1水平的影响及短期预后观察[J].中国动脉硬化杂志, 2017, 25(3):264-268.
[4] 刘睿方, 徐方兴, 刘同库. 急性ST段抬高型心肌梗死患者的支架植入时机研究[J].中国全科医学, 2017, 20(4):432-436.
[5] Franchi F, Rollini F, Angiolillo DJ.Antithrombotic therapy for patients with STEMI undergoing primary PCI.[J].Nature Rev Cardiol,2017, 14(6):361.
[6] Yang L. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients[J].Minerva Cardioangiol,2017, 65(2):111-118.
[7] Wang Y. Ticagrelor in acute stroke or transient ischemic attack in Asian patients: from the SOCRATES Trial (acute stroke or transient ischemic attack treated with aspirin or ticagrelor and patient outcomes)[J].Stroke,2017, 48(1):167-173.
[8] Guimar es LF. P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.[J].Int J Cardiol,2017, 230:204-208.
[9] Hiatt WR, Fowkes FG, Heizer G, et al. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.[J].New Engl J Med,2017, 376(1):32.
[10] 郭宏, 王安杏, 孙牧. 急性冠脉综合征患者血清TNF-α、CD40L、IL-1β水平与继发室性心律失常的相关性分析[J].中国医药导报, 2016, 13(23):83-86. |
2019, Vol. 36 
